BlackBarn Capital Partners LP raised its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 61.7% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 97,000 shares of the company's stock after purchasing an additional 37,000 shares during the quarter. Molina Healthcare accounts for 1.6% of BlackBarn Capital Partners LP's portfolio, making the stock its 3rd largest position. BlackBarn Capital Partners LP owned 0.17% of Molina Healthcare worth $28,232,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently bought and sold shares of MOH. Versant Capital Management Inc grew its stake in Molina Healthcare by 83.1% in the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company's stock worth $47,000 after purchasing an additional 74 shares in the last quarter. Wingate Wealth Advisors Inc. acquired a new position in shares of Molina Healthcare in the 4th quarter worth approximately $52,000. Hurley Capital LLC acquired a new stake in shares of Molina Healthcare during the 4th quarter valued at approximately $55,000. EverSource Wealth Advisors LLC lifted its stake in Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after purchasing an additional 88 shares during the last quarter. Finally, Whittier Trust Co. of Nevada Inc. boosted its holdings in Molina Healthcare by 337.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock worth $58,000 after purchasing an additional 155 shares during the period. 98.50% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Molina Healthcare
In related news, Director Steven J. Orlando sold 1,000 shares of Molina Healthcare stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the completion of the sale, the director now owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. The trade was a 5.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.10% of the company's stock.
Molina Healthcare Stock Up 0.3 %
Shares of NYSE MOH traded up $0.88 during mid-day trading on Friday, reaching $314.69. The company had a trading volume of 755,041 shares, compared to its average volume of 672,240. The stock has a fifty day moving average of $319.39 and a two-hundred day moving average of $307.68. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $365.23. The company has a market capitalization of $17.21 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 1.06 and a beta of 0.70. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.62 and a current ratio of 1.62.
Molina Healthcare (NYSE:MOH - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported $6.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.86 by $0.22. The company had revenue of $11.15 billion during the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. During the same quarter last year, the business posted $5.73 EPS. As a group, equities research analysts expect that Molina Healthcare, Inc. will post 24.4 EPS for the current year.
Analyst Ratings Changes
A number of research firms have recently issued reports on MOH. Sanford C. Bernstein initiated coverage on shares of Molina Healthcare in a research report on Tuesday. They issued an "outperform" rating and a $414.00 price target on the stock. StockNews.com raised shares of Molina Healthcare from a "hold" rating to a "buy" rating in a report on Friday, April 11th. Stephens reaffirmed an "equal weight" rating and set a $345.00 target price on shares of Molina Healthcare in a report on Thursday, February 6th. Truist Financial raised their price target on Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Finally, UBS Group lowered their price objective on Molina Healthcare from $374.00 to $325.00 and set a "neutral" rating for the company in a research note on Friday, February 7th. Nine analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $365.38.
Read Our Latest Stock Analysis on MOH
Molina Healthcare Profile
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Further Reading

Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.